Nonprofit research institutes advancing neuroscience, cell biology, and immunology through open science
The Allen Institute operates four research institutes focused on unlocking bioscience complexity through large-scale, multi-disciplinary studies. The tech stack—Python, R, AWS, plus specialized sequencing tools (RNA-seq, ATAC-seq, Sanger, qPCR, ddPCR) and spatial transcriptomics platforms—reflects a research-first organization built around molecular and genomic workflows. Active hiring is heavily skewed toward research roles (45 of 72 open positions), with emerging investment in data infrastructure (6 roles) and ML scalability—signaling a shift toward computational biology at scale.
The Allen Institute is a nonprofit research organization headquartered in Seattle, founded to accelerate foundational bioscience research and advance human health. The institute operates four specialized research institutes: Brain Science, Cell Science, Immunology, and the Paul G. Allen Frontiers Group. The organization pursues large-scale collaborative research across neuroscience, cell biology, and immunology using open science principles. Current projects span spatial transcriptomics, next-generation sequencing pipelines, brain health moonshot initiatives, and AI/ML scalability standards. The institute faces operational challenges typical of multi-site research organizations: integrating multimodal datasets, modeling disease trajectories, managing international team collaboration, and reducing experimental bottlenecks.
Python, R, AWS for computing; Illumina, qPCR, ddPCR, Sanger sequencing, RNA-seq, ATAC-seq for experimental work; Benchling for lab management; Zarr for data storage.
Headquartered in Seattle, Washington, with 501–1,000 employees. Founded in 2003 as a nonprofit research organization.
Other companies in the same industry, closest in size